EPISODE · Dec 10, 2025 · 37 MIN
Atropine approval: What does it mean for the management of myopia?
from EyePod: The optometry podcast · host The College of Optometrists
College Clinical Advisers Denise Voon MCOptom, Dr Paramdeep Bilkhu MCOptom, and Daniel Hardiman-McCartney FCOptom MBE discuss the recent news from the Medicines and Healthcare products Regulatory Agency (MHRA) approving the first low-dose atropine treatment for myopia in the UK. They talk about what the news means for optometrists and answer questions from College members. Further informationMyopia managementGuidance for assessing and managing children with myopiaMHRA approves first licensed low-dose atropine treatment for childhood myopia in the UKExpanding Prescribing Scope of Practice - Royal Pharmaceutical Society
What this episode covers
College Clinical Advisers Denise Voon MCOptom, Dr Paramdeep Bilkhu MCOptom, and Daniel Hardiman-McCartney FCOptom MBE discuss the recent news from the Medicines and Healthcare products Regulatory Agency (MHRA) approving the first low-dose atropine treatment for myopia in the UK. They talk about what the news means for optometrists and answer questions from College members. Further informationMyopia managementGuidance for assessing and managing children with myopiaMHRA approves first licensed low-dose atropine treatment for childhood myopia in the UKExpanding Prescribing Scope of Practice - Royal Pharmaceutical Society
NOW PLAYING
Atropine approval: What does it mean for the management of myopia?
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.